Patrick E. Vigren is Consultant Neurosurgeon and Head of Neurology Department, Linkoping University Hospital. He did his MD From Karolinska Institute and PhD from Linkoping University in 2004 and 2017 respectively. He is Chairman of Regional Stroke Council and Regional Board of Neural Disorders from 2015 and 2012 respectively. He is President and Founder of Student Body of Swedish Society of Medicine. He got Honorary President award for his contribution towards Student Body of Swedish Society of Medicine. His research areas are focused in field of Neurology, Neurosurgery and Stroke.
Dr. K. P. Singh is currently working as a professor in the Department of Zoology, University of Allahabad, Allahabad, INDIA. He started his research on Developmental Neurotoxicity of CNS Acting Drugs covering the broad area of neuropsycopharmacology including neuroanatomy, pharmacology, neurochemistry and neurobehaviour in rodent (Rat/Mice) model. At present, his neurobiology laboratory is involved to investigate the effect of novel pschycotropic (Antiepileptic, Antipsychotic, Antidepressant) drug exposure during pregnancy and lactation on fetal/neonatal birth defects, neuropathological alterations in different regions of fetal brain viz, Cerebral cortex, Caudate putamen, Hippocampus and Cerebellum etc., neurodevelopmental delay in offspring as well as longâ€“lasting impact on neurobehavioural impairment in young-adult offspring. This laboratory is also engaged to find out the involved interactive mechanisms through neurotransmitters, nerve growth factors, apoptotic neurodegeneration, pro-apoptotic (Bax) and anti-apoptotic (Bcl2) protein expression, glial-neuronal cell interactions and genotoxicity of drugs.
Mervat Nasry Wahba is a Neurologist in Memphis, Tennessee and is affiliated with multiple hospitals in the area, including Baptist Memorial Hospital-Memphis and Methodist Hospitals of Memphis. She has completed her Medical degree at Cairo University School of Medicine and has been in practice for more than 20 years. She is one of the 62 doctors at Baptist Memorial Hospital-Memphis and one of 52 doctors at Methodist Hospitals of Memphis who specialize in Neurology.
Yasser Awaad, is a Professor of Pediatric Neurology at University of Michigan. He is certified by American Board Certification in Neurology with special competence in Child Neurology. He is ex-Chairman of Pediatric Neurology Department, King Fahad Medical City. He established the First Pediatric Neurology Department and Residency Program at KFMC. He was the founder of Movement Disorders Clinic at the Children Hospital of Michigan, Oakwood Hospital & KFMC. He was founder of the Spasticity Program at the Children Hospital of Michigan, Oakwood Hospital & KFMC. He has 70 publications in peer review journals. He has delivered multiple presentations as a Guest Speaker, nationally and internationally in various meeting, conferences and symposium. He is an associate editor on several Medical Journals. He has 2 written chapters (Pediatric movement disorders, Spasticity in Children) in Pediatric text books.
Dr Jay Seitz is a neuropsychologist, health consultant, entrepreneur, writer, arts supporter, and canine and nature aficionado (hiking, mountain/trail biking, and off-roading). Formerly, he was a practicing neuropsychologist but is currently launching a healthcare startup. Neurocognitive Therapeutics, LLC is a healthcare startup specializing in helping everyday consumers leverage developments in phytonutrients and nutraceuticals to enhance cognition and higher-order cognitive abilities for healthy aging as well as general well-being of body and mind. He just finished a book in evolutionary cognitive neuroscience on the evolutionary origins of complex cognitive abilities in modern humans as well as an article on neuroaesthetics.
Feng Zheng, graduating as Doctor of Medicine from Medical School of University of Cologne, Germany and now working as Associate Professor at Dept. of Neurosurgery, First Affiliated Hospital of Gannan Medical University, China, has his expertise in neuro-oncology and cerebrovascular disease. In the medical centre, there are more than 250 patients with neural tumors receiving micro-surgeries and endoscopic surgeries, and over 300 patients with cerebrovascular disease receiving endovascular treatment and micro-surgeries per year, which allows contributions of clinical research to Neuroscience. The author looks forward to cooperation with international colleagues.